Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Assessing the efficacy and tolerability of PET-guided BrE... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
0
Authors
Peter Borchmann
49 more
Peter Borchmann
•
Gundolf Schneider
47 more
•
Volker Diehl
Published
July 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Biology
Cancer Oncology
Medicine
Paleontology
Internal Medicine
Show all topics
DOI
10.1016/s0140-6736(24)01315-1
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Biology
Cancer Oncology
Medicine
Paleontology
Internal Medicine
Show all topics
DOI
10.1016/s0140-6736(24)01315-1
License
CC-BY
